Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Eczema Health Center

Font Size

Exciting New Eczema Treatment Expected This Year

WebMD Health News

March 17, 2000 (San Francisco) -- A new class of medications to treat eczema may soon hit the market, according to researchers at a dermatology meeting. These new treatments are very effective and do not have the long-term side effects, such as damage to the skin, that are seen with the currently available steroid creams and ointments.

Eczema, also known as atopic dermatitis, afflicts 6% of all Americans -- 15 million adults and children -- with red and inflamed patches of skin that are uncontrollably itchy. The condition burdens mostly children, and although nearly half of them outgrow the condition, the rest suffer with it their entire lives.

Although prescription treatments are available, no new topical medications specifically for eczema have been introduced in more than four decades. Now, a new type of drugs, called topical immunomodulators (TIMs), is showing encouraging results in human studies. Like steroids, these new medications calm down the overactive immune system that is the cause of the skin condition associated with eczema. However, unlike steroid creams and ointments, they do not appear to cause the thinning of the skin that makes the skin more susceptible to sun damage. Dermatologists learned about the new treatment this week at the 58th Annual Meeting of the American Academy of Dermatology (AAD) here in San Francisco.

"Finally, after 40 years, a [new] option that appears [to be] very safe," dermatologist and researcher Amy Paller, MD, tells WebMD. "[Development of] this new class of drugs is extremely exciting." Paller is a pediatric dermatologist at Children's Memorial Hospital in Chicago.

Two TIMs are in development, tacrolimus and ascomycin, and unlike many current eczema creams and ointments, they are steroid-free. The new class of drugs has been tested in 2,000 children and adults, and "it looks very effective," Paller says. Currently undergoing approval by the FDA, researchers expect TIMs will be available later this year.

For many, the launch of TIMs can't come soon enough. Since 1970, the incidence of eczema has nearly tripled. "Physicians, adult patients, and parents of young children with eczema are always looking for new treatment options that relieve the discomfort of this condition," Paller says. The beauty of the new agent, she says, is that, in contrast to topical steroids, TIMs have shown no evidence of side effects.

Today on WebMD

woman meditating
Learn how to deal with a key trigger: stress.
Getting your eczema under control?
man with eczema
Does it affect your eczema?
makeup brushes and foundation
And be educated when shopping for cosmetics.
Antipsychotic Drugs Blood Clots
Eczema Emotional Effects
young woman touching skin
Eczema on arm

Itching for Relief?

Get Help With the

Loading ...

Sending your email...

This feature is temporarily unavailable. Please try again later.


Now check your email account on your mobile phone to download your new app.